Veradermics, Inc (MANE)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

130.90 on 9 Oct 2026

7 buys2 sales at will2 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$70.00M

Free cash flow

$71.63M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
19 Aug 2026	MONTANOVA CAPITAL, LLC Director	Sold at will	$80.44M	61.9%
17 Aug 2026	Waldman Reid Alexander Chief Executive Officer	Sold on a plan	$7.28M	28.3%
17 Aug 2026	Durso Timothy August Chief Technical Officer	Sold on a plan	$4.69M	35.8%
12 Aug 2026	CHILDS JOHN W Director	Sold at will	$10.71M	34.0%
6 Feb 2026	MONTANOVA CAPITAL, LLC Director	Bought	$1.11M	6.2%
5 Feb 2026	Longitude Capital Partners V, LLC 10% owner	Bought	$18.28M	70.5%

23out of 100

Profitability 0

Financial strength 10

Growth n/a

Insiders 75

Strongest on insiders (75), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$54.09M

7 buys, 5 buyers

Sold

$103.12M

4 sales

Planned sales

50%

under a 10b5-1 plan